Brian Burkavage is Chief Accounting Officer of IO Biotech, Inc.. Currently has a direct ownership of 11,500 shares of IOBT, which is worth approximately $11,270. The most recent transaction as insider was on Nov 22, 2023, when has been sold 5,000 shares (Common Stock) at a price of $1.03 per share, resulting in proceeds of $5,150. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 11.5K
0% 3M change
0% 12M change
Total Value Held $11,270

Brian Burkavage Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 22 2023
BUY
Open market or private purchase
$5,150 $1.03 p/Share
5,000 Added 30.3%
11,500 Common Stock
Nov 21 2023
BUY
Open market or private purchase
$4,950 $0.99 p/Share
5,000 Added 43.48%
6,500 Common Stock
BB

Brian Burkavage

Chief Accounting Officer
Copenhagen, G7

Track Institutional and Insider Activities on IOBT

Follow IO Biotech, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IOBT shares.

Notify only if

Insider Trading

Get notified when an Io Biotech, Inc. insider buys or sells IOBT shares.

Notify only if

News

Receive news related to IO Biotech, Inc.

Track Activities on IOBT